NCT06726616 Physical and Cognitive Aging Study in Older Adults
| NCT ID | NCT06726616 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Florida |
| Condition | Older Adults (65 Years and Older) |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-03-19 |
| Primary Completion | 2027-09-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-03-19 with a primary completion date of 2027-09-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Hispanic Americans are the fastest growing older adult group in the United States, disproportionally increasing the risk of an Alzheimer's disease and related dementias diagnosis. Efforts to reduce this risk and mitigate the related cognitive/physical declines are critical. The aim of this study is to assess the feasibility of enrolling older adults into an aging trajectory cohort, while generating preliminary data on associations of physical and cognitive aging trajectories. Our secondary objective is to generate preliminary data on the association of standard measures of physical activity and physical function with cognitive status. This study fits within our longitudinal research goal to reduce dementia incidence by understanding the mechanisms that drive the cognitive-physical aging trajectory.
Eligibility Criteria
Inclusion Criteria: • Hispanic and non-Hispanic adults age 55-85 years, at least 8th grade education, community dwelling. Additional Inclusion for Hispanic Americans * Self-identify as Hispanic American * Report Spanish as primary language • No evidence of dementia or mild cognitive impairment based on cognitive screening \[i.e., Montreal Cognitive Assessment (MoCA) administered during Visit 1; ≥26 among non-Hispanic White, ≥25 among Hispanics, ≥24 among non-Hispanic Blacks (Milani et al., 2018)\] Exclusion Criteria: * Inability to provide informed consent * Artificial joint or severe disability that would make it impossible or contraindicated performing the isokinetic test * Sensory loss (vision, hearing) or motor deficits that would preclude participation in the experimental tasks or neuropsychological assessment * Previous major strokes or other known significant brain abnormalities or diseases affecting the brain and/or cognition (e.g., Parkinson disease, multiple sclerosis, seizure disorder, brain surgery, moderate TBI, REM Behavior Sleep Disorder, untreated sleep apnea, etc.) * Unstable and uncontrolled medical conditions (metastatic cancer, HIV, moderate-severe kidney disease, uncontrolled diabetes, uncontrolled hypertension, severe cardiac disease, etc.). No current cancer diagnosis. * Current or past history of major psychiatric disturbance including schizophrenia, or active psychosis, bipolar disorder, current major depressive episode, current alcohol or substance abuse or history thereof within the past six months * Use of antipsychotics, sedatives, or other medications with significant anticholinergic properties (due to potential influence on memory) * Use of prescribed 'memory enhancing' medications, such as Aricept or Namenda * Previous participation in a cognitive or physical activity training study within the last 6 months or current involvement in another study involving cognitive, physical or other intervention at the time of enrollment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06726616 clinical trial?
This trial is open to participants of all sexes, aged 55 Years or older, up to 85 Years, studying Older Adults (65 Years and Older). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06726616 currently recruiting?
Yes, NCT06726616 is actively recruiting participants. Contact the research team at salvarezalvarado@ufl.edu for enrollment information.
Where is the NCT06726616 trial being conducted?
This trial is being conducted at Jacksonville, United States.
Who is sponsoring the NCT06726616 clinical trial?
NCT06726616 is sponsored by University of Florida. The trial plans to enroll 100 participants.